Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 4

The impact of SHS exposure on health status and exacerbations among patients with COPD

Authors Mark D Eisner, Carlos Iribarren, Edward H Yelin, Stephen Sidney, et al.

Published Date May 2009 Volume 2009:4 Pages 169—176

DOI http://dx.doi.org/10.2147/COPD.S4681

Published 6 May 2009

Mark D Eisner1,3, Carlos Iribarren3, Edward H Yelin2, Stephen Sidney3, Patricia P Katz2, Gabriela Sanchez3, Paul D Blanc1

1Division of Occupational and Environmental Medicine and Division of Pulmonary and Critical Care Medicine; 2Institute for Health Policy Studies, Department of Medicine, University of California, San Francisco, CA, USA; 3Division of Research, Kaiser Permanente, Oakland, CA, USA

Abstract: Secondhand smoke (SHS) is a major contributor to indoor air pollution. Because it contains respiratory irritants, it may adversely influence the clinical course of persons with chronic obstructive pulmonary disease (COPD). We used data from nonsmoking members of the FLOW cohort of COPD (n = 809) to elucidate the impact of SHS exposure on health status and exacerbations (requiring emergency department visits or hospitalization). SHS exposure was measured by a validated survey instrument (hours of exposure during the past week). Physical health status was measured by the SF-12 Physical Component Summary Score and disease-specific health-related quality of life (HRQL) by the Airways Questionnaire 20-R. Health care utilization for COPD was determined from Kaiser Permanente Northern California computerized databases. Compared to no SHS exposure, higher level SHS exposure was associated with poorer physical health status (mean score decrement −1.78 points; 95% confidence interval [CI] −3.48 to −0.074 points) after controlling for potential confounders. Higher level SHS exposure was also related to poorer disease-specific HRQL (mean score increment 0.63; 95% CI 0.016 to 1.25) and less distance walked during the Six-Minute Walk test (mean decrement −50 feet; 95% CI −102 to 1.9). Both lower level and higher level SHS exposure was related to increased risk of emergency department (ED) visits (hazard ratio [HR] 1.40; 95% CI 0.96 to 2.05 and HR 1.41; 95% CI 0.94 to 2.13). Lower level and higher level SHS exposure were associated with a greater risk of hospital-based care for COPD, which was a composite endpoint of either ED visits or hospitalizations for COPD (HR 1.52; 95% CI 1.06 to 2.18 and HR 1.40; 95% CI 0.94 to 2.10, respectively). In conclusion, SHS was associated with poorer health status and a greater risk of COPD exacerbation. COPD patients may comprise a vulnerable population for the health effects of SHS.

Keywords: chronic obstructive pulmonary disease, chronic bronchitis, pulmonary emphysema, tobacco smoke pollution

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

COPD and cognitive impairment: the role of hypoxemia and oxygen therapy

Neeta Thakur, Paul D Blanc, Laura J Julian, et al

International Journal of Chronic Obstructive Pulmonary Disease 2010, 5:263-269

Published Date: 10 August 2010

Readers of this article also read:

Polymeric nanoparticle-based delivery of microRNA-199a-3p inhibits proliferation and growth of osteosarcoma cells

Zhang L, Iyer AK, Yang X, Kobayashi E, Guo Y, Mankin H, Hornicek FJ, Amiji MM, Duan Z

International Journal of Nanomedicine 2015, 10:2913-2924

Published Date: 15 April 2015

Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity

Lim JP, Leung BP, Ding YY, Tay L, Ismail NH, Yeo A, Yew S, Chong MS

Clinical Interventions in Aging 2015, 10:605-609

Published Date: 25 March 2015

Sustained-release nanoART formulation for the treatment of neuroAIDS

Jayant RD, Atluri VSR, Agudelo M, Sagar V, Kaushik A, Nair M

International Journal of Nanomedicine 2015, 10:1077-1093

Published Date: 4 February 2015

Sustained-release G-CSF microspheres using a novel solid-in-oil-in-oil-in-water emulsion method

Liu G, Hong X, Jiang M, Yuan W

International Journal of Nanomedicine 2012, 7:4559-4569

Published Date: 17 August 2012

Solid lipid nanoparticles modified with stearic acid–octaarginine for oral administration of insulin

Zhang ZH, Zhang YL, Zhou JP, Lv HX

International Journal of Nanomedicine 2012, 7:3333-3339

Published Date: 2 July 2012

Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species

Javed Akhtar M, Ahamed M, Kumar S, Khan MM, Ahmad J, Alrokayan SA

International Journal of Nanomedicine 2012, 7:845-857

Published Date: 21 February 2012

Nanomedicine for the reduction of the thrombogenicity of stent coatings

Varvara C Karagkiozaki, Stergios D Logothetidis, Spyridon N Kassavetis, et al

International Journal of Nanomedicine 2010, 5:239-248

Published Date: 29 March 2010